Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shugan Jieyu Jiaonang for Generalized Anxiety Disorder (Phase II/III, Stage 1)
CTR20230577Phase 3Completed
- Sponsor
- Sichuan Jishengtang Pharmaceutical Co., Ltd.
- Start
- Apr 2023
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Shugan Jieyu in generalized anxiety disorder (GAD), sponsored by Sichuan Jishengtang Pharmaceutical Co., Ltd.. Started Apr 2023; status: completed.
02
Drugs
Shugan Jieyu
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on CTR20230577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230577.